| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 6.15e-16 | 46 | 71 | 10 | GO:0030020 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 3.83e-10 | 12 | 71 | 5 | GO:0048407 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 1.21e-09 | 188 | 71 | 10 | GO:0005201 |
| GeneOntologyMolecularFunction | growth factor binding | 2.35e-04 | 156 | 71 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 BSN COL1A1 | 2.90e-04 | 891 | 71 | 11 | GO:0005198 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 5.53e-07 | 377 | 70 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 5.66e-07 | 378 | 70 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 5.80e-07 | 379 | 70 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 5.97e-06 | 76 | 70 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 7.22e-06 | 79 | 70 | 5 | GO:0060350 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 8.06e-06 | 12 | 70 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | replacement ossification | 1.36e-05 | 43 | 70 | 4 | GO:0036075 | |
| GeneOntologyBiologicalProcess | endochondral ossification | 1.36e-05 | 43 | 70 | 4 | GO:0001958 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 2.95e-05 | 18 | 70 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 6.41e-05 | 124 | 70 | 5 | GO:0060349 | |
| GeneOntologyBiologicalProcess | skeletal system development | COL2A1 COL3A1 COL18A1 ZBTB7A SLC38A10 NAB2 GNAS AXIN1 COL1A1 | 2.26e-04 | 615 | 70 | 9 | GO:0001501 |
| GeneOntologyBiologicalProcess | negative regulation of tubulin deacetylation | 2.36e-04 | 7 | 70 | 2 | GO:1904428 | |
| GeneOntologyBiologicalProcess | bone development | 2.74e-04 | 264 | 70 | 6 | GO:0060348 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 3.55e-04 | 277 | 70 | 6 | GO:0048705 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 WDR33 COL1A1 | 8.04e-15 | 88 | 71 | 11 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 4.31e-13 | 21 | 71 | 7 | GO:0098644 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 8.46e-09 | 8 | 71 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 ANO8 COL1A1 | 1.51e-08 | 332 | 71 | 11 | GO:0005788 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 5.92e-08 | 12 | 71 | 4 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 5.92e-08 | 12 | 71 | 4 | GO:0098643 | |
| GeneOntologyCellularComponent | basement membrane | 1.89e-07 | 122 | 71 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 7.45e-07 | 6 | 71 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.08e-06 | 8 | 71 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.08e-06 | 8 | 71 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 1.16e-05 | 530 | 71 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 7.11e-05 | 656 | 71 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 7.29e-05 | 658 | 71 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.13e-04 | 5 | 71 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | postsynaptic endosome membrane | 6.13e-04 | 11 | 71 | 2 | GO:0098895 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 6.15e-04 | 114 | 71 | 4 | GO:0005798 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 TFPT MAP6 MAPT FMN2 COL1A1 | 2.10e-03 | 1187 | 71 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.75e-03 | 23 | 71 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | presynapse | 2.99e-03 | 886 | 71 | 9 | GO:0098793 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 3.20e-03 | 293 | 71 | 5 | GO:0030658 | |
| GeneOntologyCellularComponent | postsynaptic endosome | 3.51e-03 | 26 | 71 | 2 | GO:0098845 | |
| HumanPheno | Cervical insufficiency | 1.29e-06 | 4 | 36 | 3 | HP:0030009 | |
| HumanPheno | Molluscoid pseudotumors | 1.11e-05 | 7 | 36 | 3 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 1.11e-05 | 7 | 36 | 3 | HP:0000139 | |
| HumanPheno | Genital hernia | 1.77e-05 | 8 | 36 | 3 | HP:0100823 | |
| HumanPheno | Arterial rupture | 1.77e-05 | 8 | 36 | 3 | HP:0025019 | |
| HumanPheno | Cigarette-paper scars | 3.76e-05 | 10 | 36 | 3 | HP:0001073 | |
| HumanPheno | Short distal phalanx of the 3rd finger | 4.86e-05 | 2 | 36 | 2 | HP:0004180 | |
| HumanPheno | Migraine with aura | 6.83e-05 | 12 | 36 | 3 | HP:0002077 | |
| HumanPheno | Arterial dissection | 6.83e-05 | 12 | 36 | 3 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 6.83e-05 | 12 | 36 | 3 | HP:0004947 | |
| HumanPheno | Aphasia | 7.42e-05 | 104 | 36 | 6 | HP:0002381 | |
| HumanPheno | Osteoarthritis | 8.04e-05 | 65 | 36 | 5 | HP:0002758 | |
| HumanPheno | Abnormal uterine cervix morphology | 8.83e-05 | 13 | 36 | 3 | HP:0012888 | |
| HumanPheno | Abnormal heart valve morphology | COL2A1 COL3A1 COL5A1 ABCA3 KMT2D ARVCF PIK3R2 EHMT1 FMN2 CIC NOTCH3 CAPN15 COL1A1 | 1.05e-04 | 588 | 36 | 13 | HP:0001654 |
| HumanPheno | Gastroesophageal reflux | COL2A1 COL5A1 ZBTB7A ABCA3 KMT2D ARVCF TRAPPC12 SLC18A3 EHMT1 GRIN2D GNAS COL1A1 | 1.34e-04 | 517 | 36 | 12 | HP:0002020 |
| HumanPheno | Hemiplegia | 1.45e-04 | 39 | 36 | 4 | HP:0002301 | |
| HumanPheno | Short 3rd finger | 1.45e-04 | 3 | 36 | 2 | HP:0009461 | |
| HumanPheno | Aplasia/Hypoplasia of the distal phalanx of the 3rd finger | 1.45e-04 | 3 | 36 | 2 | HP:0009421 | |
| HumanPheno | Nodular pattern on pulmonary HRCT | 1.45e-04 | 3 | 36 | 2 | HP:0025392 | |
| HumanPheno | Subcutaneous spheroids | 1.45e-04 | 3 | 36 | 2 | HP:0025014 | |
| HumanPheno | Telecanthus | 1.67e-04 | 173 | 36 | 7 | HP:0000506 | |
| HumanPheno | Abnormal cerebral cortex morphology | COL2A1 COL3A1 COL4A1 COL4A2 COL18A1 HIC1 CNNM2 KMT2D TRAPPC12 MAPT PIK3R2 EHMT1 GNAS PRRT2 AXIN1 | 1.68e-04 | 801 | 36 | 15 | HP:0002538 |
| HumanPheno | Platybasia | 2.06e-04 | 17 | 36 | 3 | HP:0002691 | |
| HumanPheno | Premature rupture of membranes | 2.06e-04 | 17 | 36 | 3 | HP:0001788 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the 3rd finger | 2.89e-04 | 4 | 36 | 2 | HP:0009447 | |
| HumanPheno | Piezogenic pedal papules | 2.89e-04 | 4 | 36 | 2 | HP:0025509 | |
| HumanPheno | Incisional hernia | 2.89e-04 | 4 | 36 | 2 | HP:0004872 | |
| HumanPheno | Abnormality of external features of the abdomen | 3.24e-04 | 326 | 36 | 9 | HP:0001462 | |
| HumanPheno | Dilatation of the cerebral artery | 4.15e-04 | 51 | 36 | 4 | HP:0004944 | |
| HumanPheno | Abnormality of the distal phalanx of the 3rd finger | 4.79e-04 | 5 | 36 | 2 | HP:0009357 | |
| HumanPheno | Subcutaneous nodule | 4.84e-04 | 95 | 36 | 5 | HP:0001482 | |
| HumanPheno | Abnormal atrioventricular valve morphology | 5.50e-04 | 350 | 36 | 9 | HP:0006705 | |
| MousePheno | abnormal vertical activity | COL18A1 SUSD4 KMT2D SLC18A3 NAB2 EHMT1 GRIN2D PPFIA3 ADCYAP1 COL1A1 RAB11FIP3 | 3.10e-06 | 439 | 62 | 11 | MP:0020167 |
| MousePheno | hearing/vestibular/ear phenotype | COL2A1 COL4A2 COL4A4 HIC1 KMT2D GTF2H3 ZDHHC5 GNAS BSN NOTCH3 AXIN1 COL1A1 HR RAB11FIP3 | 3.21e-05 | 905 | 62 | 14 | MP:0005377 |
| MousePheno | abnormal synapse morphology | 5.75e-05 | 224 | 62 | 7 | MP:0009538 | |
| MousePheno | abnormal maternal nurturing | 1.00e-04 | 105 | 62 | 5 | MP:0001386 | |
| MousePheno | increased vertical activity | 1.14e-04 | 250 | 62 | 7 | MP:0002574 | |
| MousePheno | subarachnoid hemorrhage | 1.15e-04 | 4 | 62 | 2 | MP:0031109 | |
| MousePheno | buphthalmos | 1.15e-04 | 4 | 62 | 2 | MP:0009274 | |
| MousePheno | thick dermal layer | 1.20e-04 | 22 | 62 | 3 | MP:0001245 | |
| MousePheno | abnormal maternal behavior | 1.54e-04 | 115 | 62 | 5 | MP:0008779 | |
| MousePheno | anterior polar cataract | 1.92e-04 | 5 | 62 | 2 | MP:0010259 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 2.25e-04 | 27 | 62 | 3 | MP:0008438 | |
| MousePheno | abnormal learning/memory/conditioning | ST6GAL2 SUSD4 KMT2D MAP6 MAPT SLC18A3 NAB2 ZDHHC5 EHMT1 RASSF10 GNAS PPFIA3 PRRT2 ADCYAP1 NOTCH3 | 2.59e-04 | 1239 | 62 | 15 | MP:0002063 |
| MousePheno | abnormal cognition | ST6GAL2 SUSD4 KMT2D MAP6 MAPT SLC18A3 NAB2 ZDHHC5 EHMT1 RASSF10 GNAS PPFIA3 PRRT2 ADCYAP1 NOTCH3 | 2.75e-04 | 1246 | 62 | 15 | MP:0014114 |
| MousePheno | respiratory distress | 2.79e-04 | 204 | 62 | 6 | MP:0001954 | |
| MousePheno | polar cataract | 2.87e-04 | 6 | 62 | 2 | MP:0010258 | |
| MousePheno | thymus cortex atrophy | 2.87e-04 | 6 | 62 | 2 | MP:0013585 | |
| MousePheno | abnormal nursing | 3.10e-04 | 30 | 62 | 3 | MP:0001382 | |
| MousePheno | impaired hearing | 4.50e-04 | 223 | 62 | 6 | MP:0006325 | |
| MousePheno | hyperactivity | COL18A1 KMT2D ARVCF MAP6 MAPT SLC18A3 NAB2 GNAS PPFIA3 PRRT2 CIC ADCYAP1 ANO8 RAB11FIP3 | 4.98e-04 | 1172 | 62 | 14 | MP:0001399 |
| MousePheno | abnormal social/conspecific interaction behavior | 5.15e-04 | 421 | 62 | 8 | MP:0002557 | |
| MousePheno | abnormal inhibitory synapse morphology | 5.33e-04 | 8 | 62 | 2 | MP:0020358 | |
| MousePheno | skin hyperplasia | 5.33e-04 | 8 | 62 | 2 | MP:0001214 | |
| MousePheno | abnormal skin cell number | 5.33e-04 | 8 | 62 | 2 | MP:0001213 | |
| MousePheno | macrophthalmia | 5.33e-04 | 8 | 62 | 2 | MP:0001296 | |
| MousePheno | podocyte foot process effacement | 6.27e-04 | 38 | 62 | 3 | MP:0008140 | |
| MousePheno | abnormal object recognition memory | 6.74e-04 | 90 | 62 | 4 | MP:0001458 | |
| MousePheno | irregularly shaped pupil | 6.78e-04 | 39 | 62 | 3 | MP:0001319 | |
| MousePheno | aortic dissection | 6.83e-04 | 9 | 62 | 2 | MP:0004044 | |
| MousePheno | abnormal parental behavior | 7.06e-04 | 160 | 62 | 5 | MP:0002068 | |
| MousePheno | abnormal forebrain morphology | COL2A1 COL4A1 COL4A2 COL18A1 SUSD4 KMT2D MAPT PIK3R2 ZDHHC5 EHMT1 PRRT2 REM2 AXIN1 | 7.12e-04 | 1072 | 62 | 13 | MP:0000783 |
| MousePheno | abnormal cued conditioning behavior | 7.26e-04 | 161 | 62 | 5 | MP:0001454 | |
| MousePheno | abnormal hippocampus layer morphology | 7.32e-04 | 92 | 62 | 4 | MP:0000813 | |
| Domain | Collagen | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 WDR33 COL1A1 | 1.55e-14 | 85 | 70 | 11 | IPR008160 |
| Domain | Collagen | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 WDR33 COL1A1 | 1.55e-14 | 85 | 70 | 11 | PF01391 |
| Domain | Fib_collagen_C | 2.90e-10 | 11 | 70 | 5 | IPR000885 | |
| Domain | COLFI | 2.90e-10 | 11 | 70 | 5 | PF01410 | |
| Domain | NC1_FIB | 2.90e-10 | 11 | 70 | 5 | PS51461 | |
| Domain | Fib_collagen_C | 2.90e-10 | 11 | 70 | 5 | PD002078 | |
| Domain | COLFI | 2.90e-10 | 11 | 70 | 5 | SM00038 | |
| Domain | C4 | 1.00e-06 | 6 | 70 | 3 | SM00111 | |
| Domain | - | 1.00e-06 | 6 | 70 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.00e-06 | 6 | 70 | 3 | IPR001442 | |
| Domain | C4 | 1.00e-06 | 6 | 70 | 3 | PF01413 | |
| Domain | NC1_IV | 1.00e-06 | 6 | 70 | 3 | PS51403 | |
| Domain | TSPN | 1.52e-06 | 23 | 70 | 4 | SM00210 | |
| Domain | CTDL_fold | 2.99e-06 | 107 | 70 | 6 | IPR016187 | |
| Domain | Endostatin | 1.38e-05 | 2 | 70 | 2 | PF06482 | |
| Domain | Collagenase_NC10/endostatin | 1.38e-05 | 2 | 70 | 2 | IPR010515 | |
| Domain | Laminin_G | 6.59e-05 | 58 | 70 | 4 | IPR001791 | |
| Domain | VWC | 1.54e-04 | 28 | 70 | 3 | PF00093 | |
| Domain | VWFC_1 | 3.29e-04 | 36 | 70 | 3 | PS01208 | |
| Domain | VWC | 3.87e-04 | 38 | 70 | 3 | SM00214 | |
| Domain | VWFC_2 | 3.87e-04 | 38 | 70 | 3 | PS50184 | |
| Domain | VWF_dom | 5.21e-04 | 42 | 70 | 3 | IPR001007 | |
| Domain | LamG | 5.98e-04 | 44 | 70 | 3 | SM00282 | |
| Domain | Znf_FYVE_PHD | 2.26e-03 | 147 | 70 | 4 | IPR011011 | |
| Domain | - | 5.78e-03 | 97 | 70 | 3 | 3.10.100.10 | |
| Domain | RA | 6.00e-03 | 31 | 70 | 2 | SM00314 | |
| Domain | C-type_lectin-like/link | 6.12e-03 | 99 | 70 | 3 | IPR016186 | |
| Domain | Znf_FYVE-rel | 7.19e-03 | 34 | 70 | 2 | IPR017455 | |
| Domain | RA | 8.47e-03 | 37 | 70 | 2 | PS50200 | |
| Domain | Znf_FYVE | 8.92e-03 | 38 | 70 | 2 | IPR000306 | |
| Domain | LAM_G_DOMAIN | 8.92e-03 | 38 | 70 | 2 | PS50025 | |
| Domain | ConA-like_dom | 9.22e-03 | 219 | 70 | 4 | IPR013320 | |
| Domain | ZF_FYVE | 9.85e-03 | 40 | 70 | 2 | PS50178 | |
| Domain | Laminin_G_2 | 9.85e-03 | 40 | 70 | 2 | PF02210 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 1.13e-15 | 44 | 57 | 10 | M27812 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 3.92e-14 | 61 | 57 | 10 | M27103 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL15A1 COL1A1 | 4.73e-14 | 41 | 57 | 9 | MM15538 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 1.06e-13 | 67 | 57 | 10 | M26999 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL15A1 COL1A1 | 3.29e-13 | 50 | 57 | 9 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL15A1 COL1A1 | 5.76e-13 | 53 | 57 | 9 | MM14566 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL15A1 COL1A1 | 2.20e-12 | 61 | 57 | 9 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 2.27e-12 | 90 | 57 | 10 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL15A1 COL1A1 | 3.46e-12 | 64 | 57 | 9 | M26953 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL15A1 COL1A1 | 1.73e-11 | 76 | 57 | 9 | MM14573 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL15A1 CAPN15 COL1A1 | 2.52e-11 | 114 | 57 | 10 | MM14571 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.76e-11 | 32 | 57 | 7 | MM14924 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.24e-10 | 20 | 57 | 6 | MM15061 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL15A1 CAPN15 COL1A1 | 1.96e-10 | 140 | 57 | 10 | M587 |
| Pathway | PID_SYNDECAN_1_PATHWAY | 5.72e-10 | 46 | 57 | 7 | M198 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.54e-10 | 76 | 57 | 8 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.62e-09 | 85 | 57 | 8 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.73e-09 | 57 | 57 | 7 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.09e-09 | 58 | 57 | 7 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.50e-09 | 59 | 57 | 7 | M27218 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.82e-09 | 66 | 57 | 7 | M18 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 8.33e-09 | 38 | 57 | 6 | MM14969 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.56e-08 | 42 | 57 | 6 | M7169 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.76e-08 | 74 | 57 | 7 | M160 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.13e-08 | 76 | 57 | 7 | M27219 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 CAPN15 COL1A1 | 2.61e-08 | 300 | 57 | 11 | M610 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.30e-08 | 84 | 57 | 7 | M7098 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL15A1 CAPN15 COL1A1 | 7.18e-08 | 258 | 57 | 10 | MM14572 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.19e-07 | 30 | 57 | 5 | M27772 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.90e-07 | 63 | 57 | 6 | M11187 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 3.17e-07 | 15 | 57 | 4 | M27161 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.06e-07 | 41 | 57 | 5 | M27778 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.05e-07 | 18 | 57 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.05e-07 | 18 | 57 | 4 | MM14882 | |
| Pathway | WP_FOCAL_ADHESION | 7.83e-07 | 187 | 57 | 8 | MM15913 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 8.90e-07 | 19 | 57 | 4 | MM15512 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 8.90e-07 | 19 | 57 | 4 | M27221 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.25e-06 | 199 | 57 | 8 | M7253 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.09e-06 | 30 | 57 | 4 | MM15517 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.09e-06 | 30 | 57 | 4 | M27216 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.37e-06 | 10 | 57 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.37e-06 | 10 | 57 | 3 | MM1560 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL24A1 PIK3R2 NAB2 ADCYAP1 COL1A1 | 7.61e-06 | 532 | 57 | 11 | M27870 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.01e-05 | 11 | 57 | 3 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.34e-05 | 12 | 57 | 3 | MM1526 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.62e-05 | 79 | 57 | 5 | M27643 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.74e-05 | 13 | 57 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.74e-05 | 13 | 57 | 3 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.21e-05 | 14 | 57 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.21e-05 | 14 | 57 | 3 | M6487 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.64e-05 | 43 | 57 | 4 | M39565 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.68e-05 | 302 | 57 | 8 | M39719 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.76e-05 | 15 | 57 | 3 | MM14922 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.76e-05 | 47 | 57 | 4 | MM14925 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 PIK3R2 NAB2 COL1A1 | 4.14e-05 | 418 | 57 | 9 | MM15587 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.62e-05 | 326 | 57 | 8 | MM15917 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 4.90e-05 | 18 | 57 | 3 | M39421 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 6.80e-05 | 20 | 57 | 3 | M15394 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 8.26e-05 | 261 | 57 | 7 | MM15676 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.05e-04 | 23 | 57 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.05e-04 | 23 | 57 | 3 | MM1427 | |
| Pathway | WP_FOCAL_ADHESION | 1.46e-04 | 199 | 57 | 6 | M39402 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.52e-04 | 67 | 57 | 4 | MM15345 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.71e-04 | 27 | 57 | 3 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 1.91e-04 | 28 | 57 | 3 | MM15957 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.64e-04 | 84 | 57 | 4 | M3228 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 ZSWIM8 PIK3R2 NAB2 | 4.59e-04 | 575 | 57 | 9 | M29853 |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.74e-04 | 161 | 57 | 5 | M39770 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 6.05e-04 | 96 | 57 | 4 | M39834 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 6.54e-04 | 98 | 57 | 4 | M27152 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 6.90e-04 | 43 | 57 | 3 | M53 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 1.07e-03 | 50 | 57 | 3 | M48087 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.10e-03 | 17 | 57 | 2 | M93 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.10e-03 | 17 | 57 | 2 | MM14907 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.39e-03 | 339 | 57 | 6 | M39736 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 2.72e-03 | 69 | 57 | 3 | M48052 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 3.94e-03 | 502 | 57 | 7 | MM14537 | |
| Pathway | WP_CANCER_PATHWAYS | 4.16e-03 | 507 | 57 | 7 | M48302 | |
| Pathway | WP_MTHFR_DEFICIENCY | 4.19e-03 | 24 | 57 | 2 | M39755 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 4.19e-03 | 24 | 57 | 2 | M11190 | |
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 1.84e-13 | 6 | 71 | 5 | 3571333 | |
| Pubmed | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 2.84e-12 | 175 | 71 | 10 | 28071719 | |
| Pubmed | 3.85e-12 | 9 | 71 | 5 | 8900172 | ||
| Pubmed | 7.68e-12 | 10 | 71 | 5 | 2446864 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 9.28e-12 | 135 | 71 | 9 | 28675934 |
| Pubmed | 1.02e-11 | 50 | 71 | 7 | 23658023 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.51e-11 | 97 | 71 | 8 | 27559042 | |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 2.87e-11 | 153 | 71 | 9 | 25037231 | |
| Pubmed | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 6.30e-11 | 167 | 71 | 9 | 22159717 | |
| Pubmed | 7.96e-11 | 5 | 71 | 4 | 9409248 | ||
| Pubmed | 1.32e-10 | 16 | 71 | 5 | 17881772 | ||
| Pubmed | 1.80e-10 | 39 | 71 | 6 | 33580754 | ||
| Pubmed | 3.49e-10 | 19 | 71 | 5 | 15689378 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SLC38A10 KMT2D ARVCF TRAPPC12 KANK3 MEX3D ZDHHC5 EHMT1 GEMIN5 ADGRL1 GRIN2D CIC ANO8 COL1A1 HR RAB11FIP3 | 6.01e-10 | 1105 | 71 | 16 | 35748872 |
| Pubmed | 6.76e-10 | 146 | 71 | 8 | 27068509 | ||
| Pubmed | 1.11e-09 | 8 | 71 | 4 | 3997552 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 1.11e-09 | 8 | 71 | 4 | 11867580 | |
| Pubmed | 1.11e-09 | 8 | 71 | 4 | 10382266 | ||
| Pubmed | 1.99e-09 | 9 | 71 | 4 | 9878537 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 3.28e-09 | 62 | 71 | 6 | 28344315 | |
| Pubmed | 3.32e-09 | 10 | 71 | 4 | 9415455 | ||
| Pubmed | 3.98e-09 | 64 | 71 | 6 | 22261194 | ||
| Pubmed | 5.20e-09 | 11 | 71 | 4 | 2745554 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 7.79e-09 | 12 | 71 | 4 | 12180907 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 34691289 | ||
| Pubmed | Distribution of collagen types I, III, and V in pregnant mouse endometrium. | 8.15e-09 | 3 | 71 | 3 | 17453912 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 30273997 | ||
| Pubmed | Distributions of types I, II and III collagen by region in the human supraspinatus tendon. | 8.15e-09 | 3 | 71 | 3 | 24088220 | |
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 17024418 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 26406420 | ||
| Pubmed | 8.15e-09 | 3 | 71 | 3 | 8240330 | ||
| Pubmed | 1.46e-08 | 38 | 71 | 5 | 25572963 | ||
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 1.57e-08 | 14 | 71 | 4 | 20858856 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.41e-08 | 86 | 71 | 6 | 28327460 | |
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 3.26e-08 | 4 | 71 | 3 | 7827955 | |
| Pubmed | 3.26e-08 | 4 | 71 | 3 | 29068597 | ||
| Pubmed | 3.26e-08 | 4 | 71 | 3 | 12874293 | ||
| Pubmed | Whole-exome sequencing of Finnish patients with vascular cognitive impairment. | 3.26e-08 | 4 | 71 | 3 | 33268848 | |
| Pubmed | Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. | 3.26e-08 | 4 | 71 | 3 | 2054384 | |
| Pubmed | 3.26e-08 | 4 | 71 | 3 | 11827796 | ||
| Pubmed | 4.77e-08 | 18 | 71 | 4 | 12571105 | ||
| Pubmed | 8.13e-08 | 5 | 71 | 3 | 11973338 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 8.13e-08 | 5 | 71 | 3 | 14758483 | |
| Pubmed | Neural tube opening and abnormal extraembryonic membrane development in SEC23A deficient mice. | 9.29e-08 | 21 | 71 | 4 | 26494538 | |
| Pubmed | 9.29e-08 | 21 | 71 | 4 | 27856617 | ||
| Pubmed | 1.11e-07 | 186 | 71 | 7 | 20673868 | ||
| Pubmed | 1.11e-07 | 186 | 71 | 7 | 20452482 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 1.62e-07 | 6 | 71 | 3 | 17029294 | |
| Pubmed | 1.62e-07 | 6 | 71 | 3 | 2426947 | ||
| Pubmed | 1.62e-07 | 6 | 71 | 3 | 16192629 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 1.62e-07 | 6 | 71 | 3 | 10534397 | |
| Pubmed | 1.62e-07 | 6 | 71 | 3 | 21467034 | ||
| Pubmed | 1.62e-07 | 6 | 71 | 3 | 9101290 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 1.62e-07 | 6 | 71 | 3 | 19275937 | |
| Pubmed | 1.62e-07 | 6 | 71 | 3 | 6988303 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 1.62e-07 | 6 | 71 | 3 | 9506531 | |
| Pubmed | 1.62e-07 | 6 | 71 | 3 | 7495302 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 1.62e-07 | 6 | 71 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 1.62e-07 | 6 | 71 | 3 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 1.62e-07 | 6 | 71 | 3 | 6389236 | |
| Pubmed | 1.62e-07 | 6 | 71 | 3 | 12225806 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 1.62e-07 | 6 | 71 | 3 | 8563024 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 1.62e-07 | 6 | 71 | 3 | 9673377 | |
| Pubmed | 1.62e-07 | 6 | 71 | 3 | 16556917 | ||
| Pubmed | 1.62e-07 | 6 | 71 | 3 | 11732842 | ||
| Pubmed | Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer. | 1.62e-07 | 6 | 71 | 3 | 19893454 | |
| Pubmed | 1.64e-07 | 24 | 71 | 4 | 25344368 | ||
| Pubmed | 1.95e-07 | 25 | 71 | 4 | 19180518 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.30e-07 | 26 | 71 | 4 | 34189436 | |
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 2.84e-07 | 7 | 71 | 3 | 8006028 | |
| Pubmed | 2.84e-07 | 7 | 71 | 3 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 2.84e-07 | 7 | 71 | 3 | 10716744 | |
| Pubmed | 2.84e-07 | 7 | 71 | 3 | 12847218 | ||
| Pubmed | 2.84e-07 | 7 | 71 | 3 | 7521231 | ||
| Pubmed | 2.84e-07 | 7 | 71 | 3 | 10639489 | ||
| Pubmed | 2.84e-07 | 7 | 71 | 3 | 11711546 | ||
| Pubmed | 2.84e-07 | 7 | 71 | 3 | 23273220 | ||
| Pubmed | 2.84e-07 | 7 | 71 | 3 | 1724753 | ||
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 2.84e-07 | 7 | 71 | 3 | 9334230 | |
| Pubmed | 4.20e-07 | 30 | 71 | 4 | 22171010 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 4.53e-07 | 8 | 71 | 3 | 20059976 | |
| Pubmed | 4.53e-07 | 8 | 71 | 3 | 1377218 | ||
| Pubmed | 4.53e-07 | 8 | 71 | 3 | 9164858 | ||
| Pubmed | 4.53e-07 | 8 | 71 | 3 | 18816857 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 4.53e-07 | 8 | 71 | 3 | 10970885 | |
| Pubmed | 4.53e-07 | 8 | 71 | 3 | 29422532 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 6.16e-07 | 79 | 71 | 5 | 18757743 | |
| Pubmed | 6.79e-07 | 9 | 71 | 3 | 8562707 | ||
| Pubmed | 6.79e-07 | 9 | 71 | 3 | 8995276 | ||
| Pubmed | 6.79e-07 | 9 | 71 | 3 | 12101409 | ||
| Pubmed | 6.79e-07 | 9 | 71 | 3 | 10880400 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 7.77e-07 | 248 | 71 | 7 | 24006456 | |
| Pubmed | 9.68e-07 | 10 | 71 | 3 | 9136074 | ||
| Pubmed | 9.68e-07 | 10 | 71 | 3 | 30738849 | ||
| Pubmed | 9.68e-07 | 10 | 71 | 3 | 14559231 | ||
| Pubmed | Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. | 1.24e-06 | 39 | 71 | 4 | 21606205 | |
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.33e-06 | 11 | 71 | 3 | 7500359 | |
| Pubmed | 1.33e-06 | 11 | 71 | 3 | 14998921 | ||
| Pubmed | Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. | 1.33e-06 | 11 | 71 | 3 | 15101818 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 1.33e-06 | 11 | 71 | 3 | 9731539 | |
| Interaction | LAIR2 interactions | 6.35e-12 | 49 | 71 | 8 | int:LAIR2 | |
| Interaction | MAG interactions | 7.30e-12 | 29 | 71 | 7 | int:MAG | |
| Interaction | MMP9 interactions | 3.66e-09 | 67 | 71 | 7 | int:MMP9 | |
| Interaction | C1QTNF1 interactions | 1.48e-08 | 47 | 71 | 6 | int:C1QTNF1 | |
| Interaction | TGFBI interactions | 2.37e-08 | 25 | 71 | 5 | int:TGFBI | |
| Interaction | BGN interactions | 6.26e-08 | 30 | 71 | 5 | int:BGN | |
| Interaction | PDGFA interactions | 8.80e-08 | 32 | 71 | 5 | int:PDGFA | |
| Interaction | SPARC interactions | 1.08e-07 | 65 | 71 | 6 | int:SPARC | |
| Interaction | MMP2 interactions | 6.22e-07 | 87 | 71 | 6 | int:MMP2 | |
| Interaction | PDGFB interactions | 6.65e-07 | 88 | 71 | 6 | int:PDGFB | |
| Interaction | PLOD1 interactions | COL2A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 MEX3D GEMIN5 COL1A1 | 8.44e-07 | 292 | 71 | 9 | int:PLOD1 |
| Interaction | SAA1 interactions | 1.30e-06 | 54 | 71 | 5 | int:SAA1 | |
| Interaction | TOP3B interactions | SLC38A10 KMT2D PELP1 ARVCF TRAPPC12 KANK3 MEX3D ZDHHC5 EHMT1 GEMIN5 ADGRL1 GRIN2D GNAS CIC ANO8 COL1A1 HR RAB11FIP3 | 2.31e-06 | 1470 | 71 | 18 | int:TOP3B |
| Interaction | COLGALT2 interactions | 3.83e-06 | 67 | 71 | 5 | int:COLGALT2 | |
| Interaction | THBS1 interactions | 5.70e-06 | 127 | 71 | 6 | int:THBS1 | |
| Interaction | PPP2R2A interactions | 1.06e-05 | 301 | 71 | 8 | int:PPP2R2A | |
| Interaction | C1QC interactions | 1.43e-05 | 42 | 71 | 4 | int:C1QC | |
| Interaction | COL8A2 interactions | 1.43e-05 | 42 | 71 | 4 | int:COL8A2 | |
| Interaction | DCN interactions | 1.57e-05 | 43 | 71 | 4 | int:DCN | |
| Interaction | CD93 interactions | 1.89e-05 | 45 | 71 | 4 | int:CD93 | |
| Interaction | FGF7 interactions | 2.27e-05 | 16 | 71 | 3 | int:FGF7 | |
| Interaction | SERPINF1 interactions | 2.45e-05 | 48 | 71 | 4 | int:SERPINF1 | |
| Interaction | COL4A1 interactions | 2.45e-05 | 48 | 71 | 4 | int:COL4A1 | |
| Interaction | HABP2 interactions | 3.29e-05 | 18 | 71 | 3 | int:HABP2 | |
| Interaction | HTRA1 interactions | 3.92e-05 | 54 | 71 | 4 | int:HTRA1 | |
| Interaction | SERPINE2 interactions | 4.52e-05 | 56 | 71 | 4 | int:SERPINE2 | |
| Interaction | OSM interactions | 4.58e-05 | 20 | 71 | 3 | int:OSM | |
| Interaction | RAB3C interactions | 8.04e-05 | 24 | 71 | 3 | int:RAB3C | |
| Interaction | FBLN2 interactions | 8.64e-05 | 66 | 71 | 4 | int:FBLN2 | |
| Interaction | CTBP1 interactions | 8.89e-05 | 406 | 71 | 8 | int:CTBP1 | |
| Interaction | COL1A2 interactions | 1.66e-04 | 78 | 71 | 4 | int:COL1A2 | |
| Interaction | ENTREP1 interactions | 2.42e-04 | 86 | 71 | 4 | int:ENTREP1 | |
| Interaction | RAB3A interactions | 2.52e-04 | 87 | 71 | 4 | int:RAB3A | |
| Interaction | C1QTNF9 interactions | 2.99e-04 | 37 | 71 | 3 | int:C1QTNF9 | |
| Interaction | CTDSPL interactions | 3.13e-04 | 92 | 71 | 4 | int:CTDSPL | |
| Interaction | RAC3 interactions | 3.13e-04 | 619 | 71 | 9 | int:RAC3 | |
| Interaction | HEPACAM interactions | 3.38e-04 | 8 | 71 | 2 | int:HEPACAM | |
| Interaction | BMP3 interactions | 3.38e-04 | 8 | 71 | 2 | int:BMP3 | |
| Interaction | RCOR1 interactions | 3.38e-04 | 494 | 71 | 8 | int:RCOR1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.35e-04 | 797 | 71 | 7 | chr19p13 | |
| Cytoband | 16p13.3 | 5.72e-04 | 244 | 71 | 4 | 16p13.3 | |
| Cytoband | 19q13.33 | 6.10e-04 | 106 | 71 | 3 | 19q13.33 | |
| Cytoband | 13q34 | 3.20e-03 | 54 | 71 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 4.35e-03 | 426 | 71 | 4 | chr16p13 | |
| GeneFamily | Collagens | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 1.07e-16 | 46 | 55 | 10 | 490 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 1.96e-17 | 43 | 71 | 10 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 2.53e-17 | 44 | 71 | 10 | M3005 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL3A1 COL4A1 COL4A2 COL5A1 COL18A1 THBD FRY COL15A1 CCM2L WWC3 HECW2 KANK3 NOTCH3 COL1A1 | 7.16e-11 | 505 | 71 | 14 | M39167 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 3.03e-09 | 270 | 71 | 10 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 3.61e-09 | 275 | 71 | 10 | M5884 |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 4.32e-08 | 72 | 71 | 6 | M9908 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 5.17e-08 | 126 | 71 | 7 | M39132 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 5.53e-08 | 75 | 71 | 6 | MM1084 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 7.72e-08 | 40 | 71 | 5 | M5887 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.15e-07 | 17 | 71 | 4 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.15e-07 | 17 | 71 | 4 | M2223 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.21e-07 | 23 | 71 | 4 | M48001 | |
| Coexpression | BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN | 8.26e-07 | 118 | 71 | 6 | M34005 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.12e-06 | 29 | 71 | 4 | MM17055 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.15e-06 | 68 | 71 | 5 | M1373 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.54e-06 | 72 | 71 | 5 | MM1131 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.76e-06 | 74 | 71 | 5 | M13547 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 1.91e-06 | 33 | 71 | 4 | M9167 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 2.43e-06 | 35 | 71 | 4 | MM17054 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.44e-06 | 79 | 71 | 5 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.59e-06 | 80 | 71 | 5 | MM1285 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.76e-06 | 81 | 71 | 5 | M39253 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 3.48e-06 | 151 | 71 | 6 | M8901 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 3.71e-06 | 86 | 71 | 5 | M2259 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 4.36e-06 | 157 | 71 | 6 | MM1099 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 5.22e-06 | 162 | 71 | 6 | M45037 | |
| Coexpression | PEREZ_TP63_TARGETS | 5.41e-06 | 356 | 71 | 8 | M10761 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 6.18e-06 | 44 | 71 | 4 | M18274 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | COL2A1 COL24A1 ZBTB7A THBD HIC1 CNNM2 SUSD4 MAP6 MAPT GRIN2D ADCYAP1 HR RAB11FIP3 | 8.15e-06 | 1115 | 71 | 13 | M10371 |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 8.47e-06 | 15 | 71 | 3 | MM402 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 8.59e-06 | 102 | 71 | 5 | MM1064 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | 1.03e-05 | 389 | 71 | 8 | M39073 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP | 1.74e-05 | 200 | 71 | 6 | M331 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.89e-05 | 120 | 71 | 5 | M42505 | |
| Coexpression | PEREZ_TP53_AND_TP63_TARGETS | 2.11e-05 | 207 | 71 | 6 | M14566 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 2.48e-05 | 318 | 71 | 7 | M41707 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 2.95e-05 | 65 | 71 | 4 | M39309 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS | 3.21e-05 | 595 | 71 | 9 | M40167 | |
| Coexpression | TSENG_IRS1_TARGETS_DN | 3.22e-05 | 134 | 71 | 5 | M13907 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 3.58e-05 | 337 | 71 | 7 | MM16606 | |
| Coexpression | TSENG_IRS1_TARGETS_DN | 4.11e-05 | 141 | 71 | 5 | MM681 | |
| Coexpression | GU_PDEF_TARGETS_UP | 4.19e-05 | 71 | 71 | 4 | M3955 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 4.54e-05 | 144 | 71 | 5 | M1484 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | COL4A1 COL4A4 THBD ZDHHC5 ADGRL1 GRIN2D GNAS APBB1IP AXIN1 HR | 4.91e-05 | 786 | 71 | 10 | M2388 |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 5.17e-05 | 148 | 71 | 5 | MM1010 | |
| Coexpression | DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS | 5.98e-05 | 645 | 71 | 9 | M40158 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | COL3A1 COL4A1 COL4A2 ST6GAL2 SLC38A10 GTF2H3 WDR33 GNAS VPS51 SNX1 | 6.12e-05 | 807 | 71 | 10 | M16651 |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 6.35e-05 | 369 | 71 | 7 | MM16610 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_DN | 6.89e-05 | 256 | 71 | 6 | M828 | |
| Coexpression | MA_RAT_AGING_DN | 7.71e-05 | 161 | 71 | 5 | M46419 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 7.73e-05 | 83 | 71 | 4 | M2448 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 8.18e-05 | 163 | 71 | 5 | M2769 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 8.28e-05 | 385 | 71 | 7 | M39264 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | 8.28e-05 | 385 | 71 | 7 | M2840 | |
| Coexpression | SENESE_HDAC1_TARGETS_DN | 8.69e-05 | 267 | 71 | 6 | M6100 | |
| Coexpression | AIZARANI_LIVER_C10_MVECS_1 | 9.05e-05 | 269 | 71 | 6 | M39114 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL3A1 COL4A1 COL4A2 COL5A1 COL18A1 HIC1 COL15A1 NOTCH3 COL1A1 | 9.06e-05 | 681 | 71 | 9 | M39175 |
| Coexpression | DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS | 9.62e-05 | 272 | 71 | 6 | MM3634 | |
| Coexpression | MA_RAT_AGING_DN | 9.97e-05 | 170 | 71 | 5 | MM16097 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | COL2A1 COL24A1 THBD SUSD4 MAP6 MAPT SLC18A3 GRIN2D GNAS ADCYAP1 APBB1IP | 1.01e-04 | 1035 | 71 | 11 | M9898 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.04e-04 | 276 | 71 | 6 | M3063 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 1.07e-04 | 34 | 71 | 3 | M1955 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 1.08e-04 | 6 | 71 | 2 | M48000 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | COL4A1 COL4A4 THBD ZDHHC5 ADGRL1 GRIN2D GNAS APBB1IP AXIN1 HR | 1.15e-04 | 871 | 71 | 10 | MM1005 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | 1.15e-04 | 703 | 71 | 9 | M39070 | |
| Coexpression | BENPORATH_EED_TARGETS | COL2A1 COL24A1 ZBTB7A THBD HIC1 CNNM2 SUSD4 MAPT SLC18A3 ADCYAP1 APBB1IP | 1.23e-04 | 1059 | 71 | 11 | M7617 |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_12HR | 1.28e-04 | 36 | 71 | 3 | M4389 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 1.28e-04 | 36 | 71 | 3 | MM833 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_12HR | 1.28e-04 | 36 | 71 | 3 | MM513 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 1.76e-04 | 192 | 71 | 5 | M42501 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 1.79e-04 | 305 | 71 | 6 | M19875 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.85e-04 | 194 | 71 | 5 | M39122 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4 | 1.86e-04 | 307 | 71 | 6 | M6386 | |
| Coexpression | CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL | 1.89e-04 | 41 | 71 | 3 | M39320 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | 2.03e-04 | 312 | 71 | 6 | M39161 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 2.08e-04 | 199 | 71 | 5 | M6264 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN | 2.13e-04 | 200 | 71 | 5 | M6263 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.13e-04 | 200 | 71 | 5 | M5930 | |
| Coexpression | GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 2.13e-04 | 200 | 71 | 5 | M9554 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN | 2.13e-04 | 200 | 71 | 5 | M3747 | |
| Coexpression | GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP | 2.13e-04 | 200 | 71 | 5 | M8514 | |
| Coexpression | GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP | 2.13e-04 | 200 | 71 | 5 | M7352 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL4A1 COL4A2 COL5A1 HIC1 CNNM2 KANK3 NAB2 GRIN2D RUFY1 SNX1 COL1A1 | 2.27e-04 | 1136 | 71 | 11 | M2247 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 2.38e-04 | 457 | 71 | 7 | M1613 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 2.38e-04 | 111 | 71 | 4 | M45685 | |
| Coexpression | MANALO_HYPOXIA_UP | 2.39e-04 | 205 | 71 | 5 | M259 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | COL3A1 ST6GAL2 TFPT PELP1 KANK3 FMN2 ADGRL1 BSN SRRM3 COL1A1 | 2.40e-04 | 954 | 71 | 10 | MM3689 |
| Coexpression | HAEGERSTRAND_RESPONSE_TO_IMATINIB | 2.57e-04 | 9 | 71 | 2 | M16300 | |
| Coexpression | JONES_OVARY_THECA | 2.66e-04 | 46 | 71 | 3 | M48349 | |
| Coexpression | MARCHINI_TRABECTEDIN_RESISTANCE_DN | 2.66e-04 | 46 | 71 | 3 | M8349 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 2.66e-04 | 46 | 71 | 3 | MM544 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 2.73e-04 | 211 | 71 | 5 | M12225 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 2.82e-04 | 470 | 71 | 7 | MM1053 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 2.84e-04 | 47 | 71 | 3 | M1399 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.84e-04 | 47 | 71 | 3 | M7585 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 3.02e-04 | 48 | 71 | 3 | M1246 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL4A1 COL4A2 COL5A1 HIC1 CNNM2 KANK3 NAB2 GRIN2D RUFY1 SNX1 COL1A1 | 3.58e-04 | 1198 | 71 | 11 | MM1062 |
| Coexpression | MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN | 3.59e-04 | 224 | 71 | 5 | M38981 | |
| Coexpression | PEREZ_TP53_TARGETS | COL2A1 COL4A4 ZNF750 COL18A1 FRY HIC1 COL15A1 MAP6 RASSF10 GNAS HR | 3.66e-04 | 1201 | 71 | 11 | M4391 |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 COL24A1 COL15A1 COL1A1 | 3.72e-04 | 1008 | 71 | 10 | MM17056 |
| CoexpressionAtlas | BM Top 100 - endometrium | 2.76e-06 | 66 | 71 | 5 | BM Top 100 - endometrium | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 4.26e-06 | 72 | 71 | 5 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 4.88e-06 | 74 | 71 | 5 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 COL15A1 MAP6 SLC18A3 FMN2 GRIN2D REM2 ADCYAP1 COL1A1 | 1.40e-05 | 951 | 71 | 13 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL5A1 COL24A1 ST6GAL2 COL15A1 MAPT SLC18A3 FMN2 REM2 ADCYAP1 APBB1IP COL1A1 | 1.94e-05 | 981 | 71 | 13 | Arv_EB-LF_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | 3.97e-05 | 496 | 71 | 9 | PCBC_EB_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 4.03e-05 | 497 | 71 | 9 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL2A1 COL3A1 COL4A1 COL4A2 COL5A1 HIC1 COL15A1 MAP6 SLC18A3 FMN2 REM2 ADCYAP1 COL1A1 | 6.01e-05 | 1094 | 71 | 13 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | BM Top 100 - cervix | 7.07e-05 | 66 | 71 | 4 | BM Top 100 - cervix | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 8.42e-05 | 69 | 71 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 8.91e-05 | 70 | 71 | 4 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL5A1 COL15A1 MAP6 MAPT SLC18A3 GRIN2D BSN REM2 ADCYAP1 COL1A1 | 9.56e-05 | 986 | 71 | 12 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | COL2A1 COL3A1 COL5A1 THBD HIC1 COL15A1 MAP6 MAPT SLC18A3 ADCYAP1 COL1A1 HR | 1.03e-04 | 994 | 71 | 12 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | COL2A1 COL3A1 ST6GAL2 COL15A1 MAP6 MAPT SLC18A3 FMN2 PRRT2 REM2 ADCYAP1 COL1A1 | 1.03e-04 | 994 | 71 | 12 | PCBC_EB_1000 |
| CoexpressionAtlas | BM Top 100 - coronary artery | 1.05e-04 | 73 | 71 | 4 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 1.11e-04 | 74 | 71 | 4 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | COL2A1 COL5A1 ST6GAL2 THBD HECW2 PIK3R2 KANK3 NAB2 ADGRL1 PRRT2 VPS51 AXIN1 OPLAH | 1.91e-04 | 1228 | 71 | 13 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 2.45e-04 | 496 | 71 | 8 | PCBC_EB_blastocyst_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 2.45e-04 | 496 | 71 | 8 | Arv_EB-LF_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 2.52e-04 | 498 | 71 | 8 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSKM - NLT_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.62e-04 | 501 | 71 | 8 | PCBC_ratio_MESO-30_from-OSKM - NLT_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 fibroblast_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 2.62e-04 | 501 | 71 | 8 | PCBC_ratio_MESO-30 fibroblast_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_plasmid_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 2.62e-04 | 501 | 71 | 8 | PCBC_ratio_MESO-30_from-plasmid_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | COL4A1 COL4A2 ZBTB7A FRY ARVCF MAP6 MAPT PRRT2 APBB1IP NOTCH3 | 4.70e-04 | 842 | 71 | 10 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_500 | 4.76e-04 | 416 | 71 | 7 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.04e-04 | 433 | 71 | 7 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.53e-04 | 214 | 71 | 5 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 8.75e-04 | 56 | 71 | 3 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_200 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | COL3A1 COL4A1 COL4A2 COL5A1 THBD SLC38A10 COL15A1 MAPT COL1A1 | 9.50e-04 | 761 | 71 | 9 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A1 COL4A2 COL5A1 COL18A1 COL24A1 THBD COL15A1 MAP6 COL1A1 | 3.05e-13 | 180 | 71 | 10 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL3A1 COL4A1 COL4A2 COL4A4 COL5A1 COL18A1 HECW2 NOTCH3 COL1A1 | 2.77e-11 | 196 | 71 | 9 | 12d9028f90c057c6e5cff00301793fa550e86c5a |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL3A1 COL4A1 COL4A2 COL5A1 COL18A1 COL24A1 THBD COL15A1 COL1A1 | 3.03e-11 | 198 | 71 | 9 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.20e-10 | 171 | 71 | 8 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.82e-10 | 180 | 71 | 8 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.25e-10 | 186 | 71 | 8 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.80e-10 | 188 | 71 | 8 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.72e-10 | 194 | 71 | 8 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.45e-10 | 196 | 71 | 8 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-10 | 197 | 71 | 8 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-10 | 197 | 71 | 8 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|tumor_Lung / Location, Cell class and cell subclass | 1.02e-09 | 198 | 71 | 8 | 5228c4bf2513186140c2c4eaa67a268c732bdc84 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-09 | 200 | 71 | 8 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-09 | 200 | 71 | 8 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.01e-09 | 134 | 71 | 7 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.01e-09 | 134 | 71 | 7 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.55e-09 | 162 | 71 | 7 | c5eee02836efde2108534679850c28d2b2cfce3f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-08 | 176 | 71 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-08 | 176 | 71 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.56e-08 | 180 | 71 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-08 | 183 | 71 | 7 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-08 | 186 | 71 | 7 | db4d9ac89cc1e55062ba888b3410b773340595dd | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.96e-08 | 186 | 71 | 7 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-08 | 186 | 71 | 7 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.11e-08 | 188 | 71 | 7 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.11e-08 | 188 | 71 | 7 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-08 | 188 | 71 | 7 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.19e-08 | 189 | 71 | 7 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-08 | 190 | 71 | 7 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-08 | 190 | 71 | 7 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-08 | 190 | 71 | 7 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.27e-08 | 190 | 71 | 7 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-08 | 191 | 71 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-08 | 191 | 71 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.35e-08 | 191 | 71 | 7 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.44e-08 | 192 | 71 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 2.44e-08 | 192 | 71 | 7 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-08 | 193 | 71 | 7 | 5d42979d811ee13a07dee08a3743a90776017cb4 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-08 | 193 | 71 | 7 | 97c0730aad9135ac681250b3871cc094a28f80a7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-08 | 193 | 71 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.53e-08 | 193 | 71 | 7 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.53e-08 | 193 | 71 | 7 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-08 | 193 | 71 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.62e-08 | 194 | 71 | 7 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-08 | 194 | 71 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-08 | 195 | 71 | 7 | 65fc50e3818e902028fc4226070fa57609c66b9c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-08 | 195 | 71 | 7 | 3b79e6bb525b17192ecec9e1227a29c419968144 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-08 | 195 | 71 | 7 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.71e-08 | 195 | 71 | 7 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.71e-08 | 195 | 71 | 7 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.81e-08 | 196 | 71 | 7 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.81e-08 | 196 | 71 | 7 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.81e-08 | 196 | 71 | 7 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-08 | 196 | 71 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-08 | 196 | 71 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-08 | 196 | 71 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-08 | 196 | 71 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-08 | 196 | 71 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.81e-08 | 196 | 71 | 7 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.81e-08 | 196 | 71 | 7 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.81e-08 | 196 | 71 | 7 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-08 | 197 | 71 | 7 | af819b0561c8db582c5b466d804153d69d3297e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-08 | 197 | 71 | 7 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-08 | 197 | 71 | 7 | 4a04da876a1482604452ae53c124ae68eda0bd5e | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 2.91e-08 | 197 | 71 | 7 | 353b76ca3e2aa4b8f51396e7121c4baa114083a0 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.91e-08 | 197 | 71 | 7 | e132f4b9deef6a565262c0aa0863cafe28f248e6 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-08 | 197 | 71 | 7 | 947042f888335c0829d4d5daeb623973eadb3348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-08 | 197 | 71 | 7 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.01e-08 | 198 | 71 | 7 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.01e-08 | 198 | 71 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.01e-08 | 198 | 71 | 7 | 5e274c5597d8720290d452465f0bd40637cb3f27 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.01e-08 | 198 | 71 | 7 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-08 | 198 | 71 | 7 | e9e98c20ff7b3f3851db86381550ce7085e2db9e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.01e-08 | 198 | 71 | 7 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-08 | 198 | 71 | 7 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 3.01e-08 | 198 | 71 | 7 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-08 | 199 | 71 | 7 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-08 | 199 | 71 | 7 | f1723cfd6fbb8c8903a3b167872ec8523e3be250 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-08 | 199 | 71 | 7 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 3.12e-08 | 199 | 71 | 7 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-08 | 199 | 71 | 7 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-08 | 199 | 71 | 7 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 3.12e-08 | 199 | 71 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-08 | 200 | 71 | 7 | ae6cc5462a8a254682793fb8cc348b9721c729bf | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.23e-08 | 200 | 71 | 7 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.23e-08 | 200 | 71 | 7 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-08 | 200 | 71 | 7 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.23e-08 | 200 | 71 | 7 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.23e-08 | 200 | 71 | 7 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.23e-08 | 200 | 71 | 7 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-08 | 200 | 71 | 7 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.02e-07 | 158 | 71 | 6 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-07 | 159 | 71 | 6 | 7a5c94c87b73f928d4daee507f32cbe7d90e4478 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-07 | 161 | 71 | 6 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.34e-07 | 162 | 71 | 6 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.90e-07 | 168 | 71 | 6 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | AT1-AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.22e-07 | 171 | 71 | 6 | 0b9912f07393aca889db72b40da08e0bc9bc1e8c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-07 | 174 | 71 | 6 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-07 | 177 | 71 | 6 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-07 | 177 | 71 | 6 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| Computational | ECM and collagens. | 2.72e-05 | 225 | 43 | 7 | MODULE_47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.47e-05 | 50 | 43 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.47e-05 | 50 | 43 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.47e-05 | 50 | 43 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.47e-05 | 50 | 43 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE | |
| Computational | Placenta genes. | COL2A1 COL3A1 COL4A1 ZBTB7A SLC38A10 COL15A1 SLC18A3 NOTCH3 COL1A1 | 7.20e-05 | 463 | 43 | 9 | MODULE_38 |
| Computational | Neighborhood of CDH11 | 1.29e-04 | 25 | 43 | 3 | GNF2_CDH11 | |
| Computational | Adhesion molecules. | 2.33e-04 | 141 | 43 | 5 | MODULE_122 | |
| Computational | Neighborhood of PTX3 | 3.88e-04 | 36 | 43 | 3 | GNF2_PTX3 | |
| Computational | Neighborhood of NF1 | 5.52e-04 | 170 | 43 | 5 | MORF_NF1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.03e-03 | 50 | 43 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.03e-03 | 50 | 43 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes in the cancer module 105. | 1.15e-03 | 200 | 43 | 5 | MODULE_105 | |
| Computational | Neighborhood of TFDP2 | 2.13e-03 | 230 | 43 | 5 | MORF_TFDP2 | |
| Computational | Spinal cord (neuro-development) genes. | 2.89e-03 | 360 | 43 | 6 | MODULE_12 | |
| Drug | GK-101 | 1.64e-11 | 36 | 71 | 7 | CID000161853 | |
| Drug | Madecassol | 1.03e-10 | 46 | 71 | 7 | CID000108062 | |
| Drug | strontium ranelate | 1.06e-10 | 77 | 71 | 8 | CID006918182 | |
| Drug | d-indobufen | 1.90e-10 | 50 | 71 | 7 | CID000044562 | |
| Drug | ridogrel | 2.53e-10 | 52 | 71 | 7 | CID005362391 | |
| Drug | NSC49633 | 2.91e-10 | 53 | 71 | 7 | CID000023340 | |
| Drug | AC1LAKND | 9.08e-10 | 62 | 71 | 7 | CID000470146 | |
| Drug | BPAT-143 | 1.30e-09 | 6 | 71 | 4 | CID000146249 | |
| Drug | PPACK | 2.35e-09 | 113 | 71 | 8 | CID003036757 | |
| Drug | malotilate | 2.40e-09 | 71 | 71 | 7 | CID000004006 | |
| Drug | BAPN | 2.40e-09 | 71 | 71 | 7 | CID000001647 | |
| Drug | AC1NMZ1B | 3.55e-09 | 75 | 71 | 7 | CID005034185 | |
| Drug | halofuginone lactate | 8.62e-09 | 85 | 71 | 7 | CID000062891 | |
| Drug | U0125; Down 200; 1uM; PC3; HG-U133A | COL3A1 COL4A1 COL18A1 ABCA3 ARVCF ADGRL1 PPFIA3 AXIN1 RAB11FIP3 | 1.06e-08 | 197 | 71 | 9 | 663_DN |
| Drug | 4-hydroxyproline | 1.39e-08 | 91 | 71 | 7 | CID000000825 | |
| Drug | candesartan cilexetil | 1.69e-08 | 145 | 71 | 8 | CID000002540 | |
| Drug | ticlopidine | 3.31e-08 | 103 | 71 | 7 | CID000005472 | |
| Drug | hydroxylysine | 4.90e-08 | 109 | 71 | 7 | CID000001029 | |
| Drug | AC1L1C2F | 5.22e-08 | 110 | 71 | 7 | CID000001711 | |
| Drug | AC1L9732 | 6.69e-08 | 114 | 71 | 7 | CID000439300 | |
| Drug | Tranilast sodium | 7.10e-08 | 115 | 71 | 7 | CID000005527 | |
| Drug | Collagenase | 1.16e-07 | 4 | 71 | 3 | DB00048 | |
| Drug | Selara | 1.26e-07 | 125 | 71 | 7 | CID000150310 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 1.32e-07 | 189 | 71 | 8 | CID000001413 | |
| Drug | foscarnet | 1.38e-07 | 190 | 71 | 8 | CID000003414 | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.55e-07 | 193 | 71 | 8 | 7232_DN | |
| Drug | Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.75e-07 | 196 | 71 | 8 | 4793_DN | |
| Drug | DMSe | 1.83e-07 | 132 | 71 | 7 | CID000020796 | |
| Drug | pirfenidone | 2.48e-07 | 138 | 71 | 7 | CID000040632 | |
| Drug | DL-penicillamine | 2.61e-07 | 139 | 71 | 7 | CID000004727 | |
| Drug | PCR 4099 | 2.61e-07 | 139 | 71 | 7 | CID000002806 | |
| Drug | colchine | COL2A1 COL3A1 COL4A1 COL5A1 COL18A1 COL24A1 MAPT SLC18A3 BSN COL1A1 | 2.99e-07 | 383 | 71 | 10 | CID000002833 |
| Drug | 351A | 4.05e-07 | 20 | 71 | 4 | CID000122144 | |
| Drug | AC1Q6PCP | 5.91e-07 | 230 | 71 | 8 | CID000005267 | |
| Drug | chondroitin sulfate | COL2A1 COL3A1 COL4A1 COL5A1 COL18A1 COL24A1 THBD GCFC2 RPH3AL COL1A1 | 5.96e-07 | 413 | 71 | 10 | CID000024766 |
| Drug | pyridinoline | 6.61e-07 | 99 | 71 | 6 | CID000105068 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 7.36e-07 | 162 | 71 | 7 | CID000072363 | |
| Drug | khellin | 1.06e-06 | 171 | 71 | 7 | CID000003828 | |
| Drug | prostacyclin sodium salt | 1.11e-06 | 250 | 71 | 8 | CID000000159 | |
| Drug | AC1L1DD6 | 1.44e-06 | 179 | 71 | 7 | CID000002299 | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.99e-06 | 188 | 71 | 7 | 3325_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.37e-06 | 193 | 71 | 7 | 3262_UP | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.45e-06 | 194 | 71 | 7 | 4678_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HG-U133A | 2.54e-06 | 195 | 71 | 7 | 1911_UP | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A | 2.54e-06 | 195 | 71 | 7 | 4333_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 2.63e-06 | 196 | 71 | 7 | 2229_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | 2.72e-06 | 197 | 71 | 7 | 6663_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 2.72e-06 | 197 | 71 | 7 | 6949_DN | |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.81e-06 | 198 | 71 | 7 | 5254_UP | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.81e-06 | 198 | 71 | 7 | 3246_DN | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.81e-06 | 198 | 71 | 7 | 6426_DN | |
| Drug | silibinin | 2.94e-06 | 285 | 71 | 8 | CID000005213 | |
| Drug | L-3,4-dehydroproline | 3.26e-06 | 73 | 71 | 5 | CID000094284 | |
| Drug | isodesmosine | 3.32e-06 | 33 | 71 | 4 | CID000013811 | |
| Drug | Sirius red | 4.22e-06 | 35 | 71 | 4 | CID005486818 | |
| Drug | Agronal | 4.82e-06 | 79 | 71 | 5 | CID000007511 | |
| Drug | homocystine | 5.79e-06 | 82 | 71 | 5 | CID000010010 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 5.99e-06 | 314 | 71 | 8 | CID000447989 | |
| Drug | pentaethylenehexamine | 6.27e-06 | 12 | 71 | 3 | CID000019990 | |
| Drug | AC1MRIIV | 6.57e-06 | 39 | 71 | 4 | CID003518584 | |
| Drug | PD123177 | 9.77e-06 | 43 | 71 | 4 | CID000114899 | |
| Drug | NC-4 | 1.07e-05 | 44 | 71 | 4 | CID006420119 | |
| Drug | ascorbate-2-phosphate | 1.29e-05 | 15 | 71 | 3 | ctd:C011669 | |
| Drug | deoxypyridinoline | 1.39e-05 | 98 | 71 | 5 | CID000105071 | |
| Drug | hyaluronan | 1.79e-05 | 263 | 71 | 7 | CID000024759 | |
| Drug | desmosine | 2.26e-05 | 53 | 71 | 4 | CID000025435 | |
| Drug | losartan | 2.29e-05 | 378 | 71 | 8 | CID000003961 | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.85e-05 | 190 | 71 | 6 | 3373_DN | |
| Drug | Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.02e-05 | 192 | 71 | 6 | 2873_DN | |
| Drug | trapidil | 3.03e-05 | 57 | 71 | 4 | CID000005531 | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.11e-05 | 193 | 71 | 6 | 4241_DN | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A | 3.11e-05 | 193 | 71 | 6 | 6733_DN | |
| Drug | Napelline [5008-52-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 6084_DN | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 5450_DN | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 6656_DN | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 6660_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 5587_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 6778_DN | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 71 | 6 | 4107_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | 3.30e-05 | 195 | 71 | 6 | 2805_UP | |
| Drug | Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.30e-05 | 195 | 71 | 6 | 2796_UP | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 3.30e-05 | 195 | 71 | 6 | 1688_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 5676_DN | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 4196_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 3327_DN | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 3255_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 2314_DN | |
| Drug | Racecadotril [81110-73-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 2774_UP | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 4769_DN | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.39e-05 | 196 | 71 | 6 | 7183_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 7217_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 4207_DN | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 4702_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 7273_DN | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 3859_UP | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 3411_DN | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 2870_DN | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 5301_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.49e-05 | 197 | 71 | 6 | 4998_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.59e-05 | 198 | 71 | 6 | 2080_DN | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.71e-07 | 53 | 70 | 5 | C4707243 | |
| Disease | Ehlers-Danlos syndrome | 7.10e-07 | 8 | 70 | 3 | cv:C0013720 | |
| Disease | myopathy (implicated_via_orthology) | 5.22e-06 | 48 | 70 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Developmental Porencephaly | 5.55e-06 | 2 | 70 | 2 | C4082301 | |
| Disease | Congenital porencephaly | 5.55e-06 | 2 | 70 | 2 | C0302892 | |
| Disease | PORENCEPHALY, FAMILIAL | 5.55e-06 | 2 | 70 | 2 | C1867983 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 5.55e-06 | 2 | 70 | 2 | C4551998 | |
| Disease | Post-traumatic Porencephaly | 5.55e-06 | 2 | 70 | 2 | C3698507 | |
| Disease | Porencephaly | 5.55e-06 | 2 | 70 | 2 | C4082173 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 5.55e-06 | 2 | 70 | 2 | C3281105 | |
| Disease | Dementia | 8.49e-06 | 17 | 70 | 3 | C0497327 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 1.66e-05 | 3 | 70 | 2 | C4552122 | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 1.66e-05 | 3 | 70 | 2 | C0220679 | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 1.66e-05 | 3 | 70 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.66e-05 | 3 | 70 | 2 | 614519 | |
| Disease | Profound Mental Retardation | 2.04e-05 | 139 | 70 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.04e-05 | 139 | 70 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.04e-05 | 139 | 70 | 5 | C0917816 | |
| Disease | Psychomotor Agitation | 3.32e-05 | 4 | 70 | 2 | C3887612 | |
| Disease | Akathisia | 3.32e-05 | 4 | 70 | 2 | C0392156 | |
| Disease | Nephrotic Syndrome | 3.59e-05 | 27 | 70 | 3 | C0027726 | |
| Disease | Ehlers-Danlos Syndrome | 5.52e-05 | 5 | 70 | 2 | C0013720 | |
| Disease | Keloid | 7.92e-05 | 35 | 70 | 3 | C0022548 | |
| Disease | mitochondrial myopathy (implicated_via_orthology) | 8.27e-05 | 6 | 70 | 2 | DOID:699 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 8.74e-05 | 774 | 70 | 9 | C0023893 | |
| Disease | coronary artery disease | COL2A1 COL4A1 COL4A2 COL4A4 CNNM2 ARVCF MAP6 WDR33 RASSF10 FMN2 BSN | 1.10e-04 | 1194 | 70 | 11 | EFO_0001645 |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 1.16e-04 | 7 | 70 | 2 | C1846545 | |
| Disease | Bleeding tendency | 1.16e-04 | 7 | 70 | 2 | C1458140 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 1.98e-04 | 9 | 70 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 1.98e-04 | 9 | 70 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | HIC1 ABCA3 KMT2D TRAPPC12 EHMT1 GRIN2D RUFY1 CIC NOTCH3 ZNF541 | 2.14e-04 | 1074 | 70 | 10 | C0006142 |
| Disease | Medulloblastoma | 2.31e-04 | 50 | 70 | 3 | C0025149 | |
| Disease | glucose measurement | 2.87e-04 | 380 | 70 | 6 | EFO_0004468 | |
| Disease | Nephrosclerosis | 3.01e-04 | 11 | 70 | 2 | C0027719 | |
| Disease | Retinal Detachment | 3.01e-04 | 11 | 70 | 2 | C0035305 | |
| Disease | Aortic Valve Insufficiency | 3.01e-04 | 11 | 70 | 2 | C0003504 | |
| Disease | collagen disease (implicated_via_orthology) | 3.61e-04 | 12 | 70 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | unipolar depression, multiple sclerosis | 3.61e-04 | 12 | 70 | 2 | EFO_0003761, MONDO_0005301 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 3.61e-04 | 12 | 70 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Migraine Disorders | 4.25e-04 | 13 | 70 | 2 | C0149931 | |
| Disease | Cerebrovascular accident | 4.37e-04 | 62 | 70 | 3 | C0038454 | |
| Disease | Impaired cognition | 4.96e-04 | 14 | 70 | 2 | C0338656 | |
| Disease | worry measurement | 5.01e-04 | 154 | 70 | 4 | EFO_0009589 | |
| Disease | Blood Coagulation Disorders | 6.52e-04 | 16 | 70 | 2 | C0005779 | |
| Disease | Intellectual Disability | 6.76e-04 | 447 | 70 | 6 | C3714756 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 7.35e-04 | 74 | 70 | 3 | DOID:3748 (is_marker_for) | |
| Disease | Malignant neoplasm of endometrium | 8.28e-04 | 18 | 70 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 8.28e-04 | 18 | 70 | 2 | C0346191 | |
| Disease | urinary microalbumin measurement | 1.03e-03 | 20 | 70 | 2 | EFO_0010967 | |
| Disease | Weight decreased | 1.36e-03 | 23 | 70 | 2 | C1262477 | |
| Disease | Squamous cell carcinoma of esophagus | 1.51e-03 | 95 | 70 | 3 | C0279626 | |
| Disease | Left Ventricular Hypertrophy | 1.61e-03 | 25 | 70 | 2 | C0149721 | |
| Disease | Heart valve disease | 1.74e-03 | 26 | 70 | 2 | C0018824 | |
| Disease | migraine disorder, pulse pressure measurement | 1.74e-03 | 26 | 70 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | Seizures | 1.82e-03 | 218 | 70 | 4 | C0036572 | |
| Disease | Cerebral Hemorrhage | 2.02e-03 | 28 | 70 | 2 | C2937358 | |
| Disease | Parkinsonism (implicated_via_orthology) | 2.16e-03 | 29 | 70 | 2 | DOID:0080855 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGGFPEGPEPRDSPS | 186 | O00192 | |
| SGDFPPGDGGPEPPR | 1256 | O94910 | |
| TGGGGLPAPPDDFLP | 541 | Q7Z5R6 | |
| GDPGPPGDHEDATPG | 596 | P53420 | |
| EIPGPPGFRGDMGDP | 716 | P53420 | |
| EPGPPGDDGFPGERG | 976 | P53420 | |
| GEPGSPGPPGFSGID | 1051 | P53420 | |
| PGPPGFSGIDGARGP | 1056 | P53420 | |
| LPGDAGREGFPGPPG | 721 | P08572 | |
| FPGPPGERGDPGEAN | 1221 | P08572 | |
| PGPREPTSPDGGEPG | 191 | Q99758 | |
| VDASPGGAGRDPGPP | 166 | Q9NUG4 | |
| GRDQGPDGGPDPEPG | 686 | Q9HCE9 | |
| PGERGETGPPGPAGF | 821 | P02458 | |
| ERGFPGLPGPSGEPG | 991 | P02458 | |
| VGFPGSRGDTGPPGP | 591 | P02462 | |
| SPGFPGPQGDRGFPG | 656 | P02462 | |
| DGAPGSGSPSREPGP | 446 | A6NK89 | |
| SAGPAPGLEGGPRDP | 71 | O75154 | |
| DSFPPGPESVGFPAG | 491 | O75808 | |
| LPAGPAPEEGEGGPE | 541 | Q9P2P5 | |
| APGPTGEREPAAGPG | 86 | Q96JE9 | |
| EEAGSPPFSPPAGGG | 201 | Q15742 | |
| APPSDPFRGGSGSPG | 301 | Q14526 | |
| GAPRGEGPAIPGDTP | 701 | O75145 | |
| GPPGFPRVPSAGADG | 1611 | Q9UPA5 | |
| PPDPFPGTAEQGAGG | 431 | O43593 | |
| PGDTGPQGFPGTPGD | 831 | P39060 | |
| GPPGPGLPAGFDDME | 1016 | P39060 | |
| DSPRPFGGPPASPGG | 2106 | Q9UM47 | |
| GGADGGAAPEPVPPD | 91 | Q86XN8 | |
| YAGSRGGPSVPDPGP | 406 | Q86XN8 | |
| PSEGRAGPDALGPGP | 66 | Q6XYB7 | |
| GTAGGEVEEGAPPPP | 966 | Q8IZL8 | |
| DGNPLPDFDGSEPPG | 46 | P18509 | |
| PDFDGSEPPGAGSPA | 51 | P18509 | |
| PGGAPDGSEPSPDFP | 266 | O00459 | |
| PGEGPGHSEAETGPP | 21 | Q7Z6L0 | |
| PVPGSAEEEPPSGGG | 36 | P16383 | |
| EGEDGDPSSGPPGPC | 421 | O15169 | |
| SGPPGPPGDDGERGD | 651 | P20908 | |
| SGTPGPPSGGDIRDP | 516 | Q6NY19 | |
| SPGERGETGPPGPAG | 796 | P02461 | |
| GEGDRGVSPPPSPFF | 2651 | Q5TBA9 | |
| AGGEESGSPPPDGPP | 521 | P39059 | |
| ADPFEVTGPGGPGPA | 136 | Q9NZ56 | |
| SEGPVGRDPAGPPDG | 806 | Q9HBR0 | |
| GRDPAGPPDGGPDTE | 811 | Q9HBR0 | |
| FDPTGPAGLGRPTPG | 696 | Q9H9B1 | |
| ETGTGSADPPGGPRP | 271 | Q9UNE2 | |
| DSGSGRGAPGPGPEP | 431 | A6NNA2 | |
| DGGDSGSGEPPPSPT | 486 | P07204 | |
| GQDGEPRSPPGPFDA | 506 | Q16572 | |
| GGYGDPEDPAPPPGS | 1251 | O14841 | |
| EPGPGPGSALEPGEE | 21 | Q96T51 | |
| GARPGLGGYSPPPEE | 146 | Q5JWF2 | |
| GTLGFPSPGEPGPRE | 146 | Q96JF0 | |
| EGFPGSGRPPPEQAS | 156 | Q9NP78 | |
| PGGTGSADPERPPGA | 86 | Q96RK0 | |
| GERGLGGPAPPEPDS | 131 | Q9H8M5 | |
| DRGEPGPPGPAGFAG | 801 | P02452 | |
| GYPGEDSTVLGPPGP | 1191 | Q17RW2 | |
| GDGAPPTGPGEEAPD | 606 | Q32MQ0 | |
| PGSGPGDSPEGPEGE | 11 | Q9UID3 | |
| PEPGSPAPGEGPSGR | 176 | P0C1Z6 | |
| PPFPGLEPESEGAAG | 16 | Q13596 | |
| GEGDPGPEPAGTPSP | 96 | Q8WVT3 | |
| PPAYPGSGDTDTGPG | 411 | Q5VX71 | |
| VGPGAGESPGTPPFR | 41 | Q8TEQ6 | |
| DGPPGPHDGGDRPSA | 786 | Q4KMP7 | |
| AFPGAPGEGPEARGP | 326 | P10636 | |
| AGGQRPDPGSPEGPA | 286 | Q8IYK8 | |
| HPLEPDSFSEGGPPG | 736 | Q9UPT8 | |
| DSFSEGGPPGRPKPG | 741 | Q9UPT8 | |
| GGSRGPSTFLPEPPD | 651 | A7E2V4 | |
| GRGVGSPEPGPTAPY | 616 | Q9C0B5 | |
| DEPFGGPPGSGTPSR | 1291 | Q9C0J8 | |
| GRLGDFFGDPGNPPE | 76 | Q13889 | |
| LGRDAPFSEPPGPSG | 421 | Q9ULE0 | |
| GPGPPAERPPTGDGD | 221 | O95365 | |
| PSEESPPGPGGGLED | 456 | Q9H0D2 | |
| PGSEPLLGSPDPEGG | 1221 | O14686 | |
| SPFPEEAPGPGGAGG | 26 | O15399 |